Search Results 391-400 of 18828 for Neutrophil

1. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 - Mayo Clinic

   Able to swallow whole capsules [Pending availability of granule formulation]. 6. Hematologic Function: Absolute neutrophil count ≥ 1200/µL, hemoglobin ≥ 9g/dL ...

2. A Study to Test Adding Pembrolizumab to Olaparib Alone as Therapy for Patients with Pancreatic Cancer That Has Spread with Inherited BRCA Mutations - Mayo Clinic

   Absolute neutrophil count ≥ 1,500/mcL (within 14 days of registration);; Platelets ≥ 100,000/mcL (within 14 days of registration);; Total bilirubin ≤ 1.5 ...

3. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC) > 1.000/mm3 · Absolute lymphocyte count (ALC) ≥ 300/mm3 · Platelets ≥ 50.000//mm3 · Hemoglobin > 8.0 g ...

4. Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,000/mm^3; Platelets ≥ 75,000/mm^3; Hemoglobin ≥ 8.0 g/dL (the use of transfusion or other intervention is allowed) ...

5. Individualized Temozolomide in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mL; Platelet count ≥ 100,000/mcl; Hemoglobin ≥ 9gm/mcl; Creatinine ≤ 2.5 x upper limit of normal (ULN); Aspartate ...

6. Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm^3; Platelet count ≥ 100,000/mm^3; Hemoglobin ≥ 11.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) ...

7. Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery - Mayo Clinic

   Participation eligibility · Absolute Neutrophil Count (ANC) > 1000/mm^3 · Platelet Count > 100,000/mm^3 · Total Bilirubin < 1.5 x upper limits of normal (ULN) ...

8. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

   No distant metastatic disease; Performance status - Eastern Cooperative Oncology Group (ECOG) 0-2; Absolute neutrophil count ≥ 1,500/mm^3; Platelet count ...

9. First In Human (FIH) Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma (MM) - Mayo Clinic

   ... neutrophil count eligibility requirement. 3. Hemoglobin > 8.0 g/dL - Adequate hepatic function, defined as: 1. Total bilirubin ≤1.5 x ULN 2. Transaminase ...

10. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

    Absolute neutrophil count ≥ 1.0 x 10^9 per liter (/L);; Hemoglobin ≥ 7.0 g/dL;; Platelets ≥ 50 x 10^9/L;; Total bilirubin ≤ 1.5 x Upper limit of normal ...